William Dahut

Chemically Modified Platforms for Better RNA Therapeutics

Transcription shapes 3D chromatin organization by interacting with loop extrusion

Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling

A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.